Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

YORGANCIOĞLU A. A.

SABA overuse in asthma, is it still a burden? Where we stand in disease control and management, 18 November 2022, (Full Text)

• Publication Type: Conference Paper / Full Text
• Doi Number: 10.1183/13993003.01402-2021
• Manisa Celal Bayar University Affiliated: Yes